VZCZCXRO9894
PP RUEHHM RUEHLN RUEHMA RUEHPA RUEHPB RUEHPOD
DE RUEHUJA #0861/01 1301549
ZNR UUUUU ZZH
P 091549Z MAY 08
FM AMEMBASSY ABUJA
TO RUEHC/SECSTATE WASHDC PRIORITY 2813
INFO RUEHOS/AMCONSUL LAGOS PRIORITY 9195
RUEHZK/ECOWAS COLLECTIVE
RUEHPH/CDC ATLANTA GA
RUEAUSA/DEPT OF HHS WASHDC
RUEHZN/ENVIRONMENT SCIENCE AND TECHNOLOGY COLLECTIVE

UNCLAS SECTION 01 OF 03 ABUJA 000861 
 
SIPDIS 
 
CDC FOR DIRECTORS EMERGENCY OPERATION CENTER 
 
E.O. 12958: N/A 
TAGS: TBIO EAID DEOC SOCI PGOV NI
SUBJECT: NIGERIA - RECENT OUTBREAKS OF MEASLES AND MENINGITIS 
 
¶1. Summary.  From January to April 2008 reports indicate there have 
been 20,549 suspected cases of measles (5,798 confirmed) with 
sixty-four recorded deaths.  This is compared to the 6,400 suspected 
cases for all of 2007.  About eighty percent of the confirmed cases 
for this year are in children under 5, with an estimated 92% of 
those unvaccinated.  Despite the reported high vaccination rates for 
measles, the data is often unreliable.  As of April 19, there have 
been 4,500 reported cases of cerebrospinal meningitis (CSM), with 
351 deaths.  The last CSM epidemic in Nigeria was in 1996-1997 when 
over 200,000 cases were reported with a 10% death rate.  The recent 
outbreaks have been primarily in northern Nigeria and are expected 
to increase with a major outbreak expected within the next 1-2 
years.  It is important that the Government of Nigeria (GON) adopt a 
comprehensive strategy for reducing measles mortality and containing 
CSM to halt their spread.  However, there still exists poor 
political will on immunization for major diseases and high level 
discussions must continue to highlight the inherent weaknesses in 
the GON vaccination programs.  End Summary. 
. 
Measles Primer 
-------------- 
. 
¶2. Measles is an acute, highly communicable viral disease 
distinguished by fever, cough, conjunctivitis (pink eye), and coryza 
(runny nose).  It is transmitted by airborne contact with nasal or 
throat secretions of infected persons.  A red blotchy rash generally 
appears between days 3 to 7 of the illness, beginning on the face, 
then generalizing on the remainder of the body and can last up to 
one week.  The disease is more severe in infants and adults than in 
children.  The most severe symptoms are likely to occur in 
malnourished children.  Complications can arise from the replication 
of the virus in the body, or from subsequent bacterial infection. 
Some complications include diarrhea, encephalitis, and pneumonia. 
All persons who have not had the disease or who have not been 
successfully immunized against measles are susceptible. 
. 
The Global Measles Situation 
---------------------------- 
. 
¶3. Despite the existence of a safe, effective, and inexpensive 
measles vaccine for over 40 years, measles is still the leading 
vaccine preventable killer of children around the world.  Each year 
there are about 35 million cases of measles and over 600,000 deaths 
globally.  Over 50% of all measles deaths occur in Africa.  In 2003 
the World Health Assembly adopted the target of reducing global 
measles deaths by 50% from 875,000 cases worldwide in 1999.  It 
recommends the WHO/UNICEF comprehensive immunization strategy for 
sustainable measles mortality reduction. 
. 
Measles in Nigeria 
------------------ 
. 
¶4. In the tropics, measles occurs primarily in the dry season.  As 
evidenced over the last six months in Nigeria, there have been 
numerous outbreaks.  Measles catch-up vaccination campaigns for all 
children less than 15 years were conducted in northern Nigeria in 
December 2005 and in southern Nigeria in October 2006. 
Administrative measles vaccine coverage from those campaigns was 
reported at over 90% in the north, and over 75% in the south. 
Despite the reports of high vaccination coverage, the quality of the 
data is poor and unreliable.  This, combined with poor routine 
immunization coverage for children born between 2006 and the 
present, has resulted in large numbers of children still 
unvaccinated, which is contributing to the outbreak of measles this 
year.  While the measles burden remains high in Nigeria, it is lower 
than that observed prior to the 2005/2006 catch-up campaigns. 
. 
Recent measles outbreaks in Nigeria 
----------------------------------- 
. 
¶5. Between January and April 2008 there have been over 20,549 
suspected cases of measles reported in Nigeria of which 5,798 have 
been confirmed.  Sixty-four deaths have been recorded.  This 
compares with approximately 6,400 suspected cases for 2007.  About 
eighty percent of the confirmed cases for 2008 are in children under 
¶5.  Of these, an estimated 92% are reported to be in children 
unvaccinated against measles.   States in the northern part of the 
country such as Kano, Katsina, Kebbi, Kaduna, Jigawa, and Borno are 
most heavily affected.  More outbreaks are expected during the 
measles high season due to the accumulation of susceptible children 
as a result of low routine immunization coverage. 
. 
The Government of Nigeria's (GON) Response 
------------------------------------------ 
. 
¶6. In Nigeria, one dose of measles vaccine is recommended for all 
children between 9 months and 1 year of age.  However, this 
 
ABUJA 00000861  002 OF 003 
 
 
recommendation is not attainable in the current environment where 
lack of political will, inadequate supply and poor distribution of 
the vaccine continues to erode the already weak routine immunization 
program.  In an effort to utilize the polio eradication program to 
improve the immunization coverage of other vaccines, the GON 
instituted the Immunization Plus Days (IPDs) strategy in 2006.  The 
IPDs strategy has contributed significantly to reducing the number 
of children infected with the wild polio virus.  It also provides 
the opportunity to offer some routine antigens (such as measles 
vaccine).  Despite the efforts of IPDs, and due to a very weak 
routine immunization delivery system, large numbers of children 
continue to miss vaccination, which has contributed to the outbreak 
of measles in 2008.  In an effort to reach more children with 
measles vaccine to prevent outbreaks of this kind in 2009, the GON 
is in the planning stages of a national Integrated Measles Campaign, 
which will be held in November and December 2008.  While the GON has 
committed in principle to bearing 50% of the operational costs 
associated with the upcoming campaign, sources for the majority of 
the funding is unclear and planning has remained largely inadequate 
for the enormity of this activity. 
. 
Cerebrospinal Meningitis (CSM) Primer 
------------------------------------- 
. 
¶7. CSM is an acute bacterial disease which is characterized by 
sudden onset of fever, intense headache, nausea, vomiting, neck 
stiffness and sensitivity to light.  CSM is transmitted through 
direct human contact with respiratory droplets from the nose and 
throat of infected individuals.  The incubation period is usually 
within 2 to 10 days.  CSM fatality rates can approach 50%, and 
approximately 20% of CSM survivors suffer long-term effects 
including mental retardation, hearing loss, and loss of limb use. 
Several serogroups of meningitis exist and vaccines have been 
developed to target specific serogroups.  In the event of an 
epidemic, children and young adults would likely be 
disproportionately affected.  Meningococcal polysaccharide vaccine 
is usually effective for outbreak control, and specifically 
effective for serogroups A and C. 
. 
The Global CSM Situation 
------------------------ 
. 
¶8. Epidemic meningococcal disease remains a major public health 
challenge in the African "meningitis belt" which extends from 
Senegal to Ethiopia, with a population of 300 million people.  The 
estimated number of meningitis cases in this region between 1995 and 
2005 was approximately 700,000 of whom about 10% died. 
. 
CSM in Nigeria 
-------------- 
. 
¶9. As of 19 April, there have been 4,500 reported cases of CSM in 
Nigeria since the beginning of the year, with 351 deaths. 
Sixty-four local government areas (LGAs) in 11 states have been 
affected, with 5 LGAs categorized as having crossed the epidemic 
threshold.  Historically, the African Meningitis Belt experiences a 
10-12 year cyclical pattern of CSM epidemics.  The last epidemic in 
Nigeria was 1996-1997, when more than 200,000 cases of CSM were 
reported, and a 10% death rate.  Based on historical patterns, it is 
possible that Nigeria will experience a major outbreak of CSM within 
the next 1-2 years. 
. 
Recent Outbreaks of CSM and GON Response 
---------------------------------------- 
. 
¶10. Nine states are primarily affected with CSM - Bauchi, Gombe, 
Jigawa, Katsina, Kebbi, Niger, Sokoto, Yobe and Zamfara.  It is 
expected that further outbreaks will occur this year.  The GON is in 
the process of procuring 6 million doses of CSM vaccine for covering 
the at-risk population in the affected LGAs; however, the pace is 
slow. [Comment: According to the WHO, the funding for this vaccine 
should have been available in the first week of May; however the 
Ministry of Finance has been known to significantly delay the 
release of funds for immunization activities. End Comment].  In 
addition, the GON and Development Partners (WHO, UNICEF, USAID, 
World Bank, etc.) have developed a proposal for submission to the 
International Coordinating Group (ICG) on Vaccine Provision for 
Epidemic Meningitis Control, for an additional 800,000 doses of CSM 
vaccine.  Should the GON funding be released in a timely manner, and 
the ICG vaccine be accessed, this quantity of vaccine should be 
sufficient to stem further outbreaks and position Nigeria better to 
minimize outbreaks for 2009's high CSM transmission season.  The 
Ministry of Health held a three-day training on enhanced CSM 
surveillance for State epidemiologists and laboratory personnel from 
22 high risk states between April 15-17, 2008. 
 
¶11. Comment. Measles immunization activities have the potential to 
 
ABUJA 00000861  003 OF 003 
 
 
reach many children, but often the opportunity is missed, as 
insufficient quantities of measles vaccines are available to meet 
the demand.  It is important that Nigeria adopts and promotes 
comprehensive strategies for measles mortality reduction.     These 
strategies include improving routine immunization services, 
conducting follow-up campaigns as planned for November and December 
2008, strengthening case-based surveillance for measles, and 
improving case management through vitamin A supplementation, 
antibiotics, and symptomatic treatment.  For CSM, containing a major 
outbreak and managing cases depends on accurate identification of 
the disease and laboratory confirmation of the causal organism. 
Preventive measures should include vaccinations, reducing 
overcrowding in living quarters and workplaces, particularly in 
schools and dormitories.  Unless these steps take place, CSM will 
remain a major public health challenge in Nigeria and the African 
"meningitis belt".  In general there exists poor political will from 
the GON on immunizations.  The Ambassador has engaged President 
Yar'Adua on the importance of polio eradication and immunization, 
and she and the USAID Director followed that up in a ministerial 
meeting (see Abuja 815).  While the President has indicated 
substantial concern and recognition of this problem, to date this 
has not translated to increased activity or efficiency of 
immunization program implementation or release of resources.  High 
level discussions should continue to highlight the inherent 
weaknesses in the GON immunization programs. End Comment. 
 
SANDERS